维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Perren TJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Randomised double- blind phase III trail of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: results of the ICON6 trail 显示文摘	Raja FA Perren TJ Embleton A	2013	Int J Gynecol Cancer2013，23，8：	1
2	CT appearances and prognostic significance of splenic metastasis in ovarian cancer 显示文摘	Spencer NJ Spencer JA Perren TJ	1998	Clin Radiol1998，53，6：	1
3	A phase 3 trial of be- vacizumab in ovarian cancer 显示文摘	Perren TJ Swart AM Pfisterer J	2011	New Engl J Med2011，365，26：	1
4	A phase 3 trial of bevacizumab in ovarian cancer显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
5	A phase 3 trial of bevaeizumab in ovarian eaneer显示文摘	Perren TJ Swart AM Pfisterer J	2011	New England Journal of Medicine2011，365，26：	1
6	A Phase 3 Trial of Bevaci- zumabin Ovarian Cancer显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
7	A phase 3 trial of bevacizumab in ovariancancer显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
8	A phase 3 trial of bevacizumab in ovarian cancer显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，24：	1
9	A phase 3 trial of bevacizumab in ovarian cancer显示文摘	Perren TJ Swan AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
10	Vascular endothelial growth factor(VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of Tamoxifen 显示文摘	Carder PJ Downey S Forbes MA MacLennan K Allgar V Kaufman S Hallam S Bicknell R Walker JJ Cairnduff F Selby PJ Perren TJ Lansdown M Banks RE	2000	Cancer Res2000，60，11：	1
11	A phase 3 trial of bevacizumab in ovarian cancer显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
12	Detection of colorectal cancer cells in peripheral blood by reverse- transcriptase polymerase chain reaction for cytokeratin 20 显示文摘	Wyld DK Selby P Perren TJ	1998	Int J Cancer1998，79，3：	1
13	A phase 3 trial of bevacizumab in ovarian cancer显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
14	A phase III trial of bevacizumab in ovariancancer 显示文摘	Perren TJ Swart AM Pfisterer J	2011	N Engl J Med2011，365，26：	1
15	Detection of colorectal cancer cells in peripheral blood by reverse transcriptase polymerase chain reaction for cytokeratin 20显示文摘	Wyld DK Selby P Perren TJ	1998	Int J Cancer1998，79，3：	1
16	Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20 显示文摘	Wyld DK Selby P Perren TJ	1998	Int J Cancer1998，79，4：	1
17	Detection of colorectal cancer cells in peripher al blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20显示文摘	Selby P Perren TJ	1998	Int J Cancer1998，，：	1
18	A phase 3 trial ofbevacizumab in ovarian cancer 显示文摘	Perren TJ Swart AM Pfisterer J	2011	New England Journal ofMedicine2011，365，26：	1
19	Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer显示文摘	Perren TJ Clayton RN Blackledge G Bailey LC Holder G Lynch SS	1986	Cancer Chemother Pharmacol1986，18，1：	1
20	Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reactlan for cytokeratin 20显示文摘	Wyld DK Selby P Perren TJ	1998	IntJ Cancer1998，79，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示